[PDF][PDF] Location of a VIPoma by iodine-123-vasoactive intestinal peptide scintigraphy
I Virgolini, A Kurtaran, M Leimer… - Journal of Nuclear …, 1998 - Soc Nuclear Med
123l@ j@ PReconstruction ofdataobtainedbySPECT 3 hr after intravenousinjectionof 150
MBq1@ l-V1P (300 pmol) depicts focal accumulation of tracer in pancreatic tail (coronal …
MBq1@ l-V1P (300 pmol) depicts focal accumulation of tracer in pancreatic tail (coronal …
123I-vasoactive intestinal peptide (VIP) receptor scanning: update of imaging results in patients with adenocarcinomas and endocrine tumors of the gastrointestinal …
I Virgolini, M Raderer, A Kurtaran, P Angelberger… - Nuclear medicine and …, 1996 - Elsevier
Recent data suggest that functional receptors (R) for vasoactive intestinal peptide (VIP) are
expressed on various tumor cells. The high-level expression of VIPR on tumor cells provided …
expressed on various tumor cells. The high-level expression of VIPR on tumor cells provided …
[PDF][PDF] Iodine-123-vasoactive intestinal peptide receptor scanning in patients with pancreatic cancer
M Raderer, A Kurtaran, Q Yang… - Journal of Nuclear …, 1998 - Soc Nuclear Med
MATERIALS AND METhODS Patients Sixty consecutive patients (26 women, 34 men; mean
age 59 yr) with histologically verified adenocarcinoma of the pancreas were included in this …
age 59 yr) with histologically verified adenocarcinoma of the pancreas were included in this …
Vasoactive intestinal peptide receptor scintigraphy in patients with pancreatic adenocarcinomas or neuroendocrine tumours
C Hessenius, M Bäder, H Meinhold, M Böhmig… - European journal of …, 2000 - Springer
Human adenocarcinomas of the gastroenteropancreatic system overexpress vasoactive
intestinal peptide (VIP) receptors and therefore represent logical diagnostic targets for …
intestinal peptide (VIP) receptors and therefore represent logical diagnostic targets for …
Imaging tumors in humans with Tc‐99m‐VIP
ML Thakur, CS Marcus, S Saeed… - Annals of the New …, 2000 - Wiley Online Library
Vasoactive intestinal peptide (VIP) was modified at the C terminus with a spacer and four
amino acids to serve as a chelating moiety. The modified peptide, TP 3654, was labeled with …
amino acids to serve as a chelating moiety. The modified peptide, TP 3654, was labeled with …
123I-labelled vasoactive intestinal peptide receptor scintigraphy in patients with colorectal cancer
M Raderer, A Kurtaran, M Hejna, F Vorbeck… - British journal of …, 1998 - nature.com
Recent studies have shown that various gastrointestinal tumours express substantial
amounts of vasoactive intestinal peptide (VIP) receptors. Based on these observations, we …
amounts of vasoactive intestinal peptide (VIP) receptors. Based on these observations, we …
[HTML][HTML] Contrast enhanced multi-detector CT and MR findings of a well-differentiated pancreatic vipoma
L Camera, R Severino, A Faggiano… - World Journal of …, 2014 - ncbi.nlm.nih.gov
Pancreatic vipoma is an extremely rare tumor accounting for less than 2% of endocrine
pancreatic neoplasms with a reported incidence of 0.1-0.6 per million. While cross-sectional …
pancreatic neoplasms with a reported incidence of 0.1-0.6 per million. While cross-sectional …
[PDF][PDF] Comparison of iodine-123-vasoactive intestinal peptide receptor scintigraphy and indium-111-CYT-103 immunoscintigraphy
M Raderer, A Becherer, A Kurtaran… - Journal of Nuclear …, 1996 - Soc Nuclear Med
METHODS Patients and Study Design Forty patients with histologically verified
adenocarcinoma of the colon, pancreas and stomach were randomized between scanning …
adenocarcinoma of the colon, pancreas and stomach were randomized between scanning …
99mTc-labeled vasoactive intestinal peptide receptor agonist: functional studies
VR Pallela, ML Thakur, S Chakder… - The Journal of Nuclear …, 1999 - search.proquest.com
Vasoactive intestinal peptide (VIP) is a naturally occurring 28-amino acid peptide with a
wide range of biological activities. Recent reports suggest that VIP receptors are expressed …
wide range of biological activities. Recent reports suggest that VIP receptors are expressed …
Somatostatin Receptor Scintigraphy: The Definitive Technique for Characterizing Vasoactive Intestinal Peptide–Secreting Tumors
JWW Thomason, RS Martin… - Clinical nuclear …, 2000 - journals.lww.com
Vasoactive intestinal peptide–secreting tumors (VIPomas) are extremely rare and difficult to
diagnose. The authors describe a patient who was found to have a VIPoma after 3 years of …
diagnose. The authors describe a patient who was found to have a VIPoma after 3 years of …